1. Potential of Mycobacterium tuberculosis chorismate mutase (Rv1885c) as a novel TLR4-mediated adjuvant for dendritic cell-based cancer immunotherapy
   Hyein Jeong et al, 2022, OncoImmunology CrossRef
2. Downregulation of Blimp1 inhibits the maturation of bone marrow-derived dendritic cells
   Jiansheng Xiao et al, 2018, International Journal of Molecular Medicine CrossRef
3. Dendritic Cells Pre-Pulsed with Wilms’ Tumor 1 in Optimized Culture for Cancer Vaccination
   Terutsugu Koya et al, 2020, Pharmaceutics CrossRef
4. Interleukin-21 (IL-21) Downregulates Dendritic Cell Cytokine Responses to Helicobacter pylori and Modulates T Lymphocyte IL-17A Expression in Peyer’s Patches during Infection
   Sharia Yasmin et al, 2019, Infection and Immunity CrossRef
5. Human Dendritic Cells: Their Heterogeneity and Clinical Application Potential in Cancer Immunotherapy
   Thiago A. Patente et al, 2019, Frontiers in Immunology CrossRef
6. Pharmacological modulation and genetic deletion of REV-ERBα and REV-ERBβ regulates dendritic cell development
   Mohammed Amir et al, 2020, Biochemical and Biophysical Research Communications CrossRef
7. An Experimental Model of Neuro–Immune Interactions in the Eye: Corneal Sensory Nerves and Resident Dendritic Cells
   Laura Frutos-Rincón et al, 2022, International Journal of Molecular Sciences CrossRef
8. Dendritic Cells and Myeloid Derived Suppressor Cells Fully Responsive to Stimulation via Toll-Like Receptor 4 Are Rapidly Induced from Bone-Marrow Cells by Granulocyte-Macrophage Colony-Stimulating Factor
   Ying Ying Kong et al, 2020, Vaccines CrossRef
9. Quality Verification with a Cluster−Controlled Manufacturing System to Generate Monocyte−Derived Dendritic Cells
   Haruhiko Kawaguchi et al, 2021, Vaccines CrossRef
10. Multiplex, high-throughput method to study cancer and immune cell mechanotransduction
    Abigail R. Fabiano et al, 2024, Communications Biology CrossRef